Contemporary OB/GYN week in review: vulvovaginal emergencies, ketamine for postpartum depression, and more
Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.
Contemporary OB/GYN week in review: vulvovaginal emergencies, ketamine for postpartum depression, and more
Thank you for visiting the Contemporary OB/GYN® website. Take a look at some of our top stories from last week (Monday, September 11 - Friday, September 15, 2023), and click each link to read and watch anything you may have missed.
1.) Vulvovaginal emergencies: diagnosis and treatment
Jermaine Gray, MD, provides some essential tips for various cases of vulvovaginal conditions that present in the emergency department, which was recently presented at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting.
Click here for the full article.
2.) The potential of ketamine to mitigate postpartum depression
Results from a case study analysis submitted during the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois, highlight the potential of ketamine as a potential alternative to traditional antidepressants for postpartum depression (PPD) treatment.
Click here for the full article.
3.) Long-acting reversible contraception access for a Southern Texas border population
The IPP LARC program “allowed for the provision of LARCs for women who had limited to no funds or access, especially in the postpartum period,” according to study authors of a poster presented at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting in Chicago, Illinois.
Click here for the full article.
4.) Recognizing the importance of aesthetics in cesarean section closures
In a poster featured at the 2023 Society for OB/GYN Hospitalists Annual Clinical Meeting, study investigators underline the importance of aesthetics in cesarean section closures as both providers and patients.
Click here for the full article.
5.) Reducing postpartum length of stay following vaginal or cesarean delivery
A targeted, collaborative approach to reduce length of stay (LOS) after cesarean or vaginal delivery resulted in a significant and sustained decrease in mean postpartum LOS without compromising patient safety, according to a poster featured at the 2023 Society of OB/GYN Hospitalists Annual Clinical Meeting, held in Chicago, Illinois.
Adverse pregnancy outcomes linked to midlife cardiovascular disease risk
September 11th 2024In a recent study presented at the 2024 Annual Meeting of The Menopause Society, women with certain adverse outcomes during pregnancy had an increased risk of cardiovascular disease later in life.
Read More
S4E1: New RNA platform can predict pregnancy complications
February 11th 2022In this episode of Pap Talk, Contemporary OB/GYN® sat down with Maneesh Jain, CEO of Mirvie, and Michal Elovitz, MD, chief medical advisor at Mirvie, a new RNA platform that is able to predict pregnancy complications by revealing the biology of each pregnancy. They discussed recently published data regarding the platform's ability to predict preeclampsia and preterm birth.
Listen
Phase 2b safety data for Sildenafil Cream against FSAD reported
August 26th 2024In a recent study published in The Journal of Sexual Medicine, Sildenafil Cream, 3.6% was indicated as safe and well-tolerated for use against female sexual arousal disorder in healthy premenopausal women.
Read More
